Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders

Parkinsonism and Related Disorders

Volumn 18, Issue 4, 2012, Pages 397-399

  Vallelunga, Annamaria ^a   Flaibani, Raffaella ^a   Formento Dojot, Patrizia ^a   Biundo, Roberta ^a   Facchini, Silvia ^a   Antonini, Angelo ^a  

^a IRCCS SAN CAMILLO HOSPITAL   (Italy)

Author keywords

COMT; DAT1; Dopamine agonist; Dopaminergic therapy; DRD2; Genetic; Impulse control disorder; Levodopa; Mechanisms; Parkinson disease; Pramipexole; Ropinirole; Taq1A

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER;

ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DOPAMINERGIC SYSTEM; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC DIFFERENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMPULSE CONTROL DISORDER; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION;

AGED; CATECHOL O-METHYLTRANSFERASE; COHORT STUDIES; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; EATING DISORDERS; FEMALE; GAMBLING; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; IMPULSE CONTROL DISORDERS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; PARKINSON DISEASE; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2;

EID: 84860353308     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2011.10.019     Document Type: Article

References (13)

1. Antonini A., Siri C., Santangelo G., Cilia R., Poletti M., Canesi M., et al. Impulsivity and compulsivity in drug-naïve patients with Parkinson's disease. Mov Disord 2011 Feb 15, 26(3):464-468.
2. Weintraub D. Impulse control disorders in Parkinson's disease: prevalence and possible risk factors. Parkinsonism Relat Disord 2009 Dec, 15(Suppl. 3):S110-S113.
3. Brewer J.A., Potenza M.N. The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochem Pharmacol 2008 Jan 1, 75(1):63-75. Epub 2007 Jul 3.
4. Neville M.J., Johnstone E.C., Walton R.T. Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 2004 Jun, 23(6):540-545.
5. Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C.L., Weinshilboum R.M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996 Jun, 6(3):243-250.
6. 108/158Met and DAT genotypes on prefrontal function in healthy subjects. Neuroimage 2007 Oct 1, 37(4):1437-1444. Epub 2007 Jul 4.
7. Fuke S., Suo S., Takahashi N., Koike H., Sasagawa N., Ishiura S. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 2001, 1(2):152-156.
8. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, Washington, DC. 4th ed.
9. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state" A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975 Nov, 12(3):189-198.
10. Simsek M., Al-Sharbati M., Al-Adawi S., Lawatia K. The VNTR polymorphism in the human dopamine transporter gene: improved detection and absence of association of VNTR alleles with attention-deficit hyperactivity disorder. Genet Test 2006 Spring, 10(1):31-34.
11. Voon V., Fox S.H. Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 2007 Aug, 64(8):1089-1096.
12. Pinto E., Reggers J., Gorwood P., Boni C., Scantamburlo G., Pitchot W., et al. The TaqI A DRD2 polymorphism in type II alcohol dependence: a marker of age at onset or of a familial disease?. Alcohol 2009 Jun, 43(4):271-275.
13. Comings D.E., Gade-Andavolu R., Gonzalez N., Wu S., Muhleman D., Chen C., et al. The additive effect of neurotransmitter genes in pathological gambling. Clin Genet 2001 Aug, 60(2):107-116.